Publicaciones en las que colabora con Francisco Orallo Cambeiro (70)

2013

  1. Cyclic AMP relaxation of rat aortic smooth muscle is mediated in part by decrease of depletion of intracellular Ca2+ stores and inhibition of capacitative calcium entry

    Vascular Pharmacology, Vol. 58, Núm. 1-2, pp. 98-104

2011

  1. Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors

    Journal of Medicinal Chemistry, Vol. 54, Núm. 14, pp. 5165-5173

  2. New butyrolactone from a marine-derived fungus aspergillus SP

    Journal of the Chilean Chemical Society, Vol. 56, Núm. 1, pp. 625-627

  3. Trans-resveratrol simultaneously increases cytoplasmic Ca 2+ levels and nitric oxide release in human endothelial cells

    Molecular Nutrition and Food Research, Vol. 55, Núm. 8, pp. 1237-1248

2010

  1. Antidepressant-like profile and MAO-A inhibitory activity of 4-propyl-2H-benzo[h]-chromen-2-one

    Life Sciences, Vol. 86, Núm. 21-22, pp. 819-824

  2. New pyridazinone derivatives with vasorelaxant and platelet antiaggregatory activities

    Bioorganic and Medicinal Chemistry Letters, Vol. 20, Núm. 22, pp. 6624-6627

  3. Synthesis and vasorelaxant and platelet antiaggregatory activities of a new series of 6-Halo-3-phenylcoumarins

    Molecules, Vol. 15, Núm. 1, pp. 270-279

2009

  1. A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors

    Bioorganic and Medicinal Chemistry Letters, Vol. 19, Núm. 12, pp. 3268-3270

  2. Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors

    Molecular Pharmaceutics, Vol. 6, Núm. 3, pp. 825-835

  3. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors

    Bioorganic and Medicinal Chemistry Letters, Vol. 19, Núm. 17, pp. 5053-5055

2008

  1. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors

    Journal of Medicinal Chemistry, Vol. 51, Núm. 21, pp. 6740-6751

  2. Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca 2+ responses in endothelial cells

    British Journal of Pharmacology, Vol. 154, Núm. 1, pp. 82-92

2007

  1. Effects of (-)-epigallocatechin-3-gallate in Ca2+-permeable non-selective cation channels and voltage-operated Ca2+ channels in vascular smooth muscle cells

    Life Sciences, Vol. 80, Núm. 23, pp. 2147-2153

  2. Effects of trans- and cis-resveratrol on Ca2+ handling in A7r5 vascular myocytes

    European Journal of Pharmacology, Vol. 577, Núm. 1-3, pp. 91-99

2006

  1. (-)-Trans-ε-viniferin, a polyphenol present in wines, is an inhibitor of noradrenaline and 5-hydroxytryptamine uptake and of monoamine oxidase activity

    European Journal of Pharmacology, Vol. 542, Núm. 1-3, pp. 54-60

  2. Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin-resveratrol hybrids

    Bioorganic and Medicinal Chemistry Letters, Vol. 16, Núm. 2, pp. 257-261

  3. Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity

    Biochemical and Biophysical Research Communications, Vol. 344, Núm. 2, pp. 688-695

  4. Study of the mechanisms involved in the vasorelaxation induced by (-)-epigallocatechin-3-gallate in rat aorta

    British Journal of Pharmacology, Vol. 147, Núm. 3, pp. 269-280

2005

  1. Hydralazine decreases sodium nitroprusside-induced rat aortic ring relaxation and increased cGMP production by rat aortic myocytes

    Life Sciences, Vol. 77, Núm. 24, pp. 3105-3116

  2. Implication of cyclic nucleotide phosphodiesterase inhibition in the vasorelaxant activity of the citrus-fruits flavonoid (±)-naringenin

    Planta Medica, Vol. 71, Núm. 2, pp. 99-107